Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Bladder Cancer

  Free Subscription


1 Anal Chem
1 Anticancer Res
1 Biosci Rep
1 BMC Cancer
1 Can J Urol
1 Cancer Med
2 Clin Genitourin Cancer
1 Croat Med J
1 Curr Opin Oncol
1 Eur J Histochem
1 Eur Radiol
2 Future Oncol
1 Genet Epidemiol
2 Int J Clin Oncol
1 Int J Med Sci
1 Int J Nanomedicine
1 Int J Oncol
1 J Biochem
1 J Cancer Res Clin Oncol
1 J Cell Mol Med
1 J Cell Physiol
1 J Control Release
1 J Eur Acad Dermatol Venereol
1 J Immunother
1 J Immunother Cancer
1 J Magn Reson Imaging
1 J Pathol
1 J Transl Med
1 J Vis Exp
1 J Xray Sci Technol
1 Medicine (Baltimore)
1 Nat Prod Res
1 Nat Rev Urol
1 NPJ Genom Med
1 Oncogene
1 Oncol Lett
1 Pathol Oncol Res
1 Urol Oncol
1 Urologe A
1 Virchows Arch
5 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Anal Chem

  1. WEI X, Bian F, Cai X, Wang Y, et al
    Multiplexed Detection Strategy for Bladder Cancer MicroRNAs Based on Photonic Crystal Barcodes.
    Anal Chem. 2020 Mar 31. doi: 10.1021/acs.analchem.0c00630.
    PubMed         Abstract available

    Anticancer Res

  2. CHEN M, Chang WS, Shen TC, Gong CL, et al
    Association of Nijmegen Breakage Syndrome 1 Genotypes With Bladder Cancer Risk.
    Anticancer Res. 2020;40:2011-2017.
    PubMed         Abstract available

    Biosci Rep

  3. LV J, Zhu Y, Ji A, Zhang Q, et al
    Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
    Biosci Rep. 2020 Apr 2. pii: 222532. doi: 10.1042/BSR20194337.
    PubMed         Abstract available

    BMC Cancer

  4. ZHANG Y, Ou DH, Zhuang DW, Zheng ZF, et al
    In silico analysis of the immune microenvironment in bladder cancer.
    BMC Cancer. 2020;20:265.
    PubMed         Abstract available

    Can J Urol

  5. THAKER H, Ghodoussipour S, Saffarian M, Ashrafi A, et al
    Extended hospital stay after radical cystectomy with enhanced recovery protocol.
    Can J Urol. 2019;26:9654-9659.
    PubMed         Abstract available

    Cancer Med

  6. JOBCZYK M, Stawiski K, Fendler W, Rozanski W, et al
    Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): A cohort analysis.
    Cancer Med. 2020 Mar 26. doi: 10.1002/cam4.3007.
    PubMed         Abstract available

    Clin Genitourin Cancer

  7. KAO C, McNamara M, Alley C, Spector N, et al
    A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.
    Clin Genitourin Cancer. 2019;17:e672-e677.

  8. MAKBOUL R, Hassan HM, Refaiy A, Abdelkawi IF, et al
    A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma.
    Clin Genitourin Cancer. 2019;17:e712-e719.
    PubMed         Abstract available

    Croat Med J

  9. RKMAN D, Likic R, Bebek M, Gnjidic M, et al
    Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report.
    Croat Med J. 2019;60:552-555.
    PubMed         Abstract available

    Curr Opin Oncol

  10. ALHALABI O, Rafei H, Shah A, Siefker-Radtke A, et al
    Targeting advanced urothelial carcinoma-developing strategies.
    Curr Opin Oncol. 2019;31:207-215.
    PubMed         Abstract available

    Eur J Histochem

  11. ZIARAN S, Harsanyi S, Bevizova K, Varchulova Novakova Z, et al
    Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence.
    Eur J Histochem. 2020;64.
    PubMed         Abstract available

    Eur Radiol

  12. LUO C, Huang B, Wu Y, Chen J, et al
    Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis.
    Eur Radiol. 2020 Apr 2. pii: 10.1007/s00330-020-06802.
    PubMed         Abstract available


  13. ABBASTABAR M, Sarfi M, Golestani A, Karimi A, et al
    Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer.
    EXCLI J. 2020;19:301-310.
    PubMed         Abstract available

    Future Oncol

  14. GRIVAS P, DerSarkissian M, Shenolikar R, Laliberte F, et al
    Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA.
    Future Oncol. 2019;15:3809-3818.
    PubMed         Abstract available

  15. LIU L, Zhao Y, Cui J, Chen S, et al
    Evaluation of platelet distribution width as a diagnostic and prognostic biomarker in bladder neoplasm.
    Future Oncol. 2019;15:3797-3807.
    PubMed         Abstract available

    Genet Epidemiol

  16. LIU Y, Huang J, Urbanowicz RJ, Chen K, et al
    Embracing study heterogeneity for finding genetic interactions in large-scale research consortia.
    Genet Epidemiol. 2020;44:52-66.
    PubMed         Abstract available

    Int J Clin Oncol

  17. NAGUMO Y, Kojima T, Shiga M, Kandori S, et al
    A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma.
    Int J Clin Oncol. 2020;25:354-361.
    PubMed         Abstract available

  18. MIYAKE M, Matsuyama H, Teramukai S, Kinoshita F, et al
    A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables.
    Int J Clin Oncol. 2020 Mar 30. pii: 10.1007/s10147-020-01654.
    PubMed         Abstract available

    Int J Med Sci

  19. WU Z, Zhu K, Liu Q, Liu Y, et al
    Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
    Int J Med Sci. 2020;17:762-772.
    PubMed         Abstract available

    Int J Nanomedicine

  20. SAMADDAR S, Mazur J, Boehm D, Thompson DH, et al
    Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules.
    Int J Nanomedicine. 2019;14:9547-9561.
    PubMed         Abstract available

    Int J Oncol

  21. PATEL R, Islam SA, Bommareddy RR, Smalley T, et al
    Simultaneous inhibition of atypical protein kinaseC and mTOR impedes bladder cancer cell progression.
    Int J Oncol. 2020 Mar 20. doi: 10.3892/ijo.2020.5021.
    PubMed         Abstract available

    J Biochem

  22. PENG Y, Chen Y, Chen S, Wang J, et al
    JUND-dependent upregulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer.
    J Biochem. 2020 Apr 2. pii: 5815268. doi: 10.1093.
    PubMed         Abstract available

    J Cancer Res Clin Oncol

  23. SEMENIUK-WOJTAS A, Lubas A, Cierniak S, Brzoskowska U, et al
    Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2020 Apr 1. pii: 10.1007/s00432-020-03202.
    PubMed         Abstract available

    J Cell Mol Med

  24. JIANG J, Bi Y, Liu XP, Yu D, et al
    To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
    J Cell Mol Med. 2020 Mar 31. doi: 10.1111/jcmm.15193.
    PubMed         Abstract available

    J Cell Physiol

  25. QIU JG, Shi DY, Liu X, Zheng XX, et al
    Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
    J Cell Physiol. 2019;234:6976-6982.
    PubMed         Abstract available

    J Control Release

  26. XU X, Liu K, Jiao B, Luo K, et al
    Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer.
    J Control Release. 2020 Mar 31. pii: S0168-3659(20)30180.
    PubMed         Abstract available

    J Eur Acad Dermatol Venereol

  27. LORA V, Haneke E, Scarabello A, Morrone A, et al
    Subungual metastasis: expanding the spectrum.
    J Eur Acad Dermatol Venereol. 2019;33:e282-e284.

    J Immunother

  28. YUEN C, Reid P, Zhang Z, Soliven B, et al
    Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study.
    J Immunother. 2019;42:94-96.
    PubMed         Abstract available

    J Immunother Cancer

  29. YANG Y, Jain RK, Glenn ST, Xu B, et al
    Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability.
    J Immunother Cancer. 2020;8.
    PubMed         Abstract available

    J Magn Reson Imaging

  30. HONG SB, Lee NK, Kim S, Son IW, et al
    Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    J Magn Reson Imaging. 2020 Mar 27. doi: 10.1002/jmri.27141.
    PubMed         Abstract available

    J Pathol

  31. AKGUL M, MacLennan GT, Cheng L
    Distinct mutational landscape of inverted urothelial papilloma.
    J Pathol. 2019;249:3-5.
    PubMed         Abstract available

    J Transl Med

  32. FANG W, Yang ZY, Chen TY, Shen XF, et al
    Ethnicity and survival in bladder cancer: a population-based study based on the SEER database.
    J Transl Med. 2020;18:145.
    PubMed         Abstract available

    J Vis Exp

  33. MORET R, Hellmers L, Zhang X, Gills J, et al
    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
    J Vis Exp. 2019;.
    PubMed         Abstract available

    J Xray Sci Technol

  34. TAO W, Sun C, Yao Q, Fu K, et al
    The clinical study of en Bloc transurethral resection with 980 nm Laser for treatment of primary non-muscle invasive bladder cancer.
    J Xray Sci Technol. 2020 Mar 21. pii: XST190616. doi: 10.3233/XST-190616.
    PubMed         Abstract available

    Medicine (Baltimore)

  35. CHO JM, Moon KT, Lee HJ, Shin SC, et al
    Nucleobindin 2 expression is an independent prognostic factor for bladder cancer.
    Medicine (Baltimore). 2020;99:e19597.
    PubMed         Abstract available

    Nat Prod Res

  36. PEREIRA GLDC, Almeida TC, Seibert JB, Amparo TR, et al
    Antitumor effect of Cymbopogon densiflorus (Linneu) essential oil in bladder cancer cells.
    Nat Prod Res. 2020 Apr 2:1-5. doi: 10.1080/14786419.2020.1747453.
    PubMed         Abstract available

    Nat Rev Urol

  37. MEEKS JJ, Al-Ahmadie H, Faltas BM, Taylor JA 3rd, et al
    Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
    Nat Rev Urol. 2020 Mar 31. pii: 10.1038/s41585-020-0304.
    PubMed         Abstract available

    NPJ Genom Med

  38. TESCH ME, Pater JA, Vandekerkhove G, Wang G, et al
    Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
    NPJ Genom Med. 2020;5:12.
    PubMed         Abstract available


  39. CHANDRASHEKAR DS, Chakravarthi BVSK, Robinson AD, Anderson JC, et al
    Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.
    Oncogene. 2020 Mar 30. pii: 10.1038/s41388-020-1275.
    PubMed         Abstract available

    Oncol Lett

  40. ZHU Z, Chang F, Liu J, Wang J, et al
    Comprehensive circular RNA profiling reveals the regulatory role of circ_100242/miR-145 pathway in bladder cancer.
    Oncol Lett. 2020;19:2971-2978.
    PubMed         Abstract available

    Pathol Oncol Res

  41. HARSHA BS, Manikandan R, Sreerag KS, Dorairajan LN, et al
    Eosinophilic Leukemoid Reaction with Eosinophilic Tumor Tissue Infiltration as an Extermely Poor Prognostic Factor in Urinary Bladder Cancer- a Known Entity Revisited.
    Pathol Oncol Res. 2020 Mar 29. pii: 10.1007/s12253-020-00807.
    PubMed         Abstract available

    Urol Oncol

  42. STANGL-KREMSER J, D'Andrea D, Vartolomei M, Abufaraj M, et al
    Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder.
    Urol Oncol. 2019;37:372-379.
    PubMed         Abstract available

    Urologe A

  43. SCHULZ WA, Hoffmann MJ, Niegisch G, Fussel S, et al
    [Report from the 9th symposium of the German Association for Bladder Cancer Research].
    Urologe A. 2020 Apr 2. pii: 10.1007/s00120-020-01181.
    PubMed         Abstract available

    Virchows Arch

  44. RODRIGUEZ PENA MDC, Springer SU, Taheri D, Li L, et al
    Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.
    Virchows Arch. 2020;476:423-429.
    PubMed         Abstract available

    World J Urol

  45. KOHADA Y, Goriki A, Yukihiro K, Ohara S, et al
    The risk factors of urinary tract infection after transurethral resection of bladder tumors.
    World J Urol. 2019 Mar 26. pii: 10.1007/s00345-019-02737.
    PubMed         Abstract available

  46. GRIMM T, Grimm J, Buchner A, Schulz G, et al
    Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes.
    World J Urol. 2019;37:2385-2392.
    PubMed         Abstract available

  47. LI R, Kukreja JEB, Seif MA, Petros FG, et al
    The role of metastatic burden in cytoreductive/consolidative radical cystectomy.
    World J Urol. 2019;37:2691-2698.
    PubMed         Abstract available

  48. ZAMBONI S, Moschini M, Gallina A, Colombo R, et al
    The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.
    World J Urol. 2019;37:2707-2714.
    PubMed         Abstract available

  49. YANG G, Zhang L, Liu M, Liu Q, et al
    CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder.
    World J Urol. 2019;37:2721-2726.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.